These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26303992)

  • 1. Adherence to Ivacaftor is suboptimal.
    Abbott J; Bilton D
    J Cyst Fibros; 2015 Sep; 14(5):547-8. PubMed ID: 26303992
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in bronchiectasis on CT imaging in a pediatric patient with cystic fibrosis on ivacaftor therapy.
    Hayes D; Long FR; McCoy KS; Sheikh SI
    Respiration; 2014; 88(4):345. PubMed ID: 25171465
    [No Abstract]   [Full Text] [Related]  

  • 3. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
    Rehman A; Baloch NU; Janahi IA
    N Engl J Med; 2015 Oct; 373(18):1783. PubMed ID: 26510035
    [No Abstract]   [Full Text] [Related]  

  • 4. Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation.
    Sheikh SI; Long FR; McCoy KS; Johnson T; Ryan-Wenger NA; Hayes D
    J Cyst Fibros; 2015 Jan; 14(1):84-9. PubMed ID: 25049054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
    Wainwright CE; Elborn JS; Ramsey BW
    N Engl J Med; 2015 Oct; 373(18):1783-4. PubMed ID: 26510034
    [No Abstract]   [Full Text] [Related]  

  • 6. Tezacaftor/Ivacaftor (Symdeko) for cystic fibrosis.
    Med Lett Drugs Ther; 2018 Oct; 60(1558):174-176. PubMed ID: 30335045
    [No Abstract]   [Full Text] [Related]  

  • 7. Lumacaftor/ivacaftor (Orkambi) for cystic fibrosis.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):41-2. PubMed ID: 27027688
    [No Abstract]   [Full Text] [Related]  

  • 8. Ivacaftor CFTR Potentiator Therapy is Efficient for Pancreatic Manifestations in Cystic Fibrosis.
    Kounis I; Lévy P; Rebours V
    Am J Gastroenterol; 2018 Jul; 113(7):1058-1059. PubMed ID: 29887601
    [No Abstract]   [Full Text] [Related]  

  • 9. Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N.
    Vreede CL; Berkhout MC; Sprij AJ; Fokkens WJ; Heijerman HG
    J Cyst Fibros; 2015 May; 14(3):412-3. PubMed ID: 25169789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug combination that corrects deficient protein in cystic fibrosis improves lung function.
    Mayor S
    BMJ; 2015 May; 350():h2689. PubMed ID: 25990552
    [No Abstract]   [Full Text] [Related]  

  • 11. Another Beginning for Cystic Fibrosis Therapy.
    Davis PB
    N Engl J Med; 2015 Jul; 373(3):274-6. PubMed ID: 25981385
    [No Abstract]   [Full Text] [Related]  

  • 12. A new chapter in therapy for cystic fibrosis.
    Bilton D
    Lancet Respir Med; 2015 Jul; 3(7):e20. PubMed ID: 26117158
    [No Abstract]   [Full Text] [Related]  

  • 13. [A milestone in cystic fibrosis therapy].
    Reinhardt D
    MMW Fortschr Med; 2015 Nov; 157(19):34. PubMed ID: 26953403
    [No Abstract]   [Full Text] [Related]  

  • 14. Ivacaftor therapy in siblings with cystic fibrosis-the potential implications of Itraconazole in dosage and efficacy.
    Harrison MJ; Ronan NJ; Khan KA; O'Callaghan G; Murphy DM; Plant BJ
    Pulm Pharmacol Ther; 2015 Apr; 31():49-50. PubMed ID: 25660163
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United States.
    Taylor-Cousar J; Niknian M; Gilmartin G; Pilewski JM;
    J Cyst Fibros; 2016 Jan; 15(1):116-22. PubMed ID: 25682022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes.
    Christian F; Thierman A; Shirley E; Allen K; Cross C; Jones K
    J Investig Med High Impact Case Rep; 2019; 7():2324709619842898. PubMed ID: 31010313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Report of Pregnancy During Use of Targeted Therapeutics for Cystic Fibrosis.
    Ladores S; Kazmerski TM; Rowe SM
    J Obstet Gynecol Neonatal Nurs; 2017; 46(1):72-77. PubMed ID: 27875677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor.
    Siracusa CM; Ryan J; Burns L; Wang Y; Zhang N; Clancy JP; Drotar D
    J Cyst Fibros; 2015 Sep; 14(5):621-6. PubMed ID: 26074007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stony road to phe508del CFTR pharmacotherapy: smoothing the first rock.
    Tümmler B
    Lancet Respir Med; 2014 Jul; 2(7):508-9. PubMed ID: 24973279
    [No Abstract]   [Full Text] [Related]  

  • 20. Ivacaftor for patients with cystic fibrosis.
    Wainwright CE
    Expert Rev Respir Med; 2014 Oct; 8(5):533-8. PubMed ID: 25148205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.